Marex Group plc files its Annual Report on Form 20-F

Rhea-AI Summary

Marex Group (NASDAQ: MRX) filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the SEC on March 25, 2026. The full report is available on Marex's investor website, and shareholders can request a free hard copy by email.

Key points: audited consolidated financial statements are included; hard copies available upon written email request to investors@marex.com; company overview: market access, clearing, agency and execution, market making and investment solutions across 60+ exchanges and 3,400 active clients.

News Market Reaction – MRX

+4.35%

24 alerts

+4.35% News Effect

+6.8% Peak in 24 hr 30 min

+$129M Valuation Impact

$3.10B Market Cap

0.5x Rel. Volume

On the day this news was published, MRX gained 4.35%, reflecting a moderate positive market reaction. Argus tracked a peak move of +6.8% during that session. Our momentum scanner triggered 24 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $129M to the company's valuation, bringing the market cap to $3.10B at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Ordinary shares outstanding: 72,937,470 shares Par value per share: $0.001551 Active clients: over 3,400 +5 more

8 metrics

Ordinary shares outstanding 72,937,470 shares As of year-end in Form 20-F

Par value per share $0.001551 Ordinary shares on NASDAQ Global Select Market

Active clients over 3,400 Global commodity and financial markets coverage

Exchange access more than 60 exchanges Market access across metals, energy and agriculture

Global offices more than 50 offices Footprint across Europe, Asia and the Americas

Employees over 3,000 employees Worldwide headcount

Free float 54,856,308 shares Shares float from risk context

Short interest 4.27% Short percentage of float from risk context

Market Reality Check

Price: $42.96 Vol: Volume 720,126 is below 2...

normal vol

$42.96 Last Close

Volume Volume 720,126 is below 20-day average 906,005 (relative volume 0.79x). normal

Technical Price 38.86 is trading above 200-day MA 36.59, indicating strength vs longer trend.

Peers on Argus

MRX gained 3.49% while peers showed mixed, smaller moves (e.g., SNEX and VIRT up...

MRX gained 3.49% while peers showed mixed, smaller moves (e.g., SNEX and VIRT up 0.34%, BGC and CLSK down 0.84%, HUT up 0.96%), suggesting a company-specific reaction rather than a broad sector move.

Historical Context

5 past events · Latest: Mar 17 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 17	Investor day details	Neutral	-1.5%	Announced agenda and logistics for upcoming Investor Day in New York.
Mar 03	Earnings results	Positive	-5.4%	Reported record Q4 2025 and strong FY 2025 revenue, PBT and EPS growth.
Feb 12	Earnings date set	Neutral	+0.0%	Scheduled Q4 and FY 2025 release and announced planned Investor Day timing.
Feb 06	Acquisition announced	Positive	+1.0%	Agreed to acquire Webb Traders to expand equity derivatives market making.
Dec 01	Acquisition completed	Positive	+0.8%	Completed Winterflood deal and outlined revenue and margin expectations for unit.

Pattern Detected

MRX has sometimes seen negative or muted reactions to positive fundamental news, as shown by the selloff after strong Q4/FY 2025 earnings, while acquisition updates have generally aligned with modest positive moves.

Recent Company History

Over the past few months, Marex has combined acquisitive growth with strong operating performance. The company announced the Winterflood acquisition and an expected net gain on that deal in Dec 2025, followed by another equity derivatives acquisition (Webb Traders) in Feb 2026. It then posted record Q4 and strong FY 2025 results on Mar 3, 2026, though the stock fell 5.41% afterward. Subsequent items, including earnings-date and Investor Day logistics, saw muted price moves. Today’s Form 20‑F filing fits into this pattern of ongoing disclosure and integration of recent growth.

Market Pulse Summary

This announcement centers on Marex’s Form 20‑F filing, which formalizes year-end reporting and highl...

Analysis

This announcement centers on Marex’s Form 20‑F filing, which formalizes year-end reporting and highlights extensive risk factors tied to commodity volatility, geopolitical events, regulation, and operational resilience. In recent months the company completed and pursued acquisitions, reported record Q4 and strong FY 2025 results, and continued integrating growth initiatives. Investors may focus on how identified material weaknesses in internal control over financial reporting and complex global risks interact with Marex’s expanding footprint and prior strategic moves.

Key Terms

form 20-f, ifrs accounting standards, ordinary shares, foreign private issuer, +4 more

8 terms

form 20-f regulatory

"announced that it filed its annual report on Form 20-F for the fiscal year"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

ifrs accounting standards regulatory

"has filed its annual Form 20‑F, reporting under IFRS Accounting Standards and listing"

International Financial Reporting Standards (IFRS) are a set of common rules for preparing company financial reports so numbers like profit, assets and debt are presented consistently across countries. Think of them as a standardized recipe or blueprint that helps investors compare businesses the same way they would compare cars using the same list of features; consistent reporting reduces surprises and makes it easier to assess value, risk and performance.

ordinary shares financial

"listing 72,937,470 ordinary shares outstanding as of year end"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

foreign private issuer regulatory

"As a foreign private issuer, Marex follows less frequent U.S. reporting requirements"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

internal control over financial reporting regulatory

"material weaknesses in internal control over financial reporting could affect the reliability"

Internal control over financial reporting is a company’s system of procedures and checks designed to make sure its financial statements are accurate and complete, like a set of guardrails and verification steps that catch mistakes or fraud before numbers are published. Investors care because strong controls make reported results more trustworthy, lower the risk of surprise restatements or regulatory problems, and give greater confidence when valuing the company or comparing it to peers.

beneficial ownership financial

"has reported beneficial ownership of 29,696 Ordinary Shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

restricted share awards financial

"includes 2,787 shares underlying restricted share awards that give him a contingent right"

Restricted share awards are grants of company stock given to employees or executives that cannot be sold or transferred until certain conditions—typically staying with the company for a set time or meeting performance goals—are met. They matter to investors because they can dilute existing shares when they vest, signal management’s incentives and confidence, and affect a company’s future earnings per share much like a delayed paycheck that becomes available only after you meet agreed milestones.

deferred bonus plan awards financial

"includes 192,348 shares underlying deferred bonus plan awards, which are contingent rights"

Deferred bonus plan awards are payments promised to employees or executives that are earned now but paid out later, often only if certain performance goals are met or the employee remains with the company. For investors, they matter because they influence management’s incentives and company expenses over time—like a delayed paycheck that encourages someone to stay and meet targets—and can affect future cash needs, reported compensation costs, and potential share dilution.

AI-generated analysis. Not financial advice.

NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’, NASDAQ: MRX), the diversified global financial services platform, today announced that it filed its annual report on Form 20-F for the fiscal year which ended on December 31, 2025 with the Securities and Exchange Commission on March 25, 2026. 

The full report is available via the Marex website here: https://ir.marex.com/financials/annual-reports

Marex will provide a hard copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed in writing by email to investors@marex.com.

About Marex:

Marex Group plc (NASDAQ: MRX) provides market access, infrastructure services and essential liquidity to clients across global commodity and financial markets. The Group provides comprehensive breadth and depth of coverage across four services: Clearing, Agency and Execution, Market Making and Hedging and Investment Solutions. It has a leading franchise in many major metals, energy and agricultural products, with access to more than 60 exchanges. Marex has over 3,400 active clients, including some of the largest commodity producers, consumers and traders, banks, hedge funds and asset managers. With more than 50 offices worldwide, the Group has over 3000 employees across Europe, Asia and the Americas. For more information visit www.marex.com.

Enquiries please contact:
Marex: Nicola Ratchford / Adam Strachan
+44 778 654 8889 / +1 914 200 2508
nratchford@marex.com / astrachan@marex.com

FTI Consulting US / UK
+1 716 525 7239 / +44 7976870961
marex@fticonsulting.com

FAQ

Where can investors find Marex Group (MRX) Form 20-F for the year ended December 31, 2025?

The Form 20-F is available on Marex's investor website. According to the company, the full annual report was filed with the SEC on March 25, 2026 and is accessible at the Marex investor financials and annual reports page.

How can MRX shareholders request a hard copy of Marex Group's 2025 annual report?

Shareholders can request a free hard copy by written email. According to the company, requests should be sent to investors@marex.com and the company will provide the audited consolidated financial statements free of charge.

What period does Marex Group's filed 20-F cover for MRX investors?

The filed Form 20-F covers the fiscal year ended December 31, 2025. According to the company, the annual report includes audited consolidated financial statements for that fiscal year and related disclosures.

Does Marex Group (MRX) include audited financial statements in its 2025 Form 20-F?

Yes. According to the company, the annual report on Form 20-F contains audited consolidated financial statements for the fiscal year ended December 31, 2025 and related required disclosures for investors.

What business services does Marex Group (MRX) describe in its 2025 annual report filing?

Marex describes market access, clearing, agency and execution, market making and investment solutions. According to the company, it serves over 3,400 active clients across 60+ exchanges with a global office footprint.

Who should investors contact for enquiries about Marex Group's (MRX) 2025 annual report?

Investors can contact Marex investor relations or FTI Consulting for enquiries. According to the company, contacts include Nicola Ratchford, Adam Strachan, and marex@fticonsulting.com with provided phone numbers.